New aspects of myocardial oxygen consumption. Invited review

Scandinavian Cardiovascular Journal

Volumn 34, Issue 3, 2000, Pages 233-241

  Myrmel, Truls ^a   Korvald, Christian ^a  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Cardiac efficiency; Cardioactive drugs; Myocardial oxygen consumption

Indexed keywords

ANIMAL; ENERGY METABOLISM; HEART CONTRACTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; HUMAN; METABOLISM; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; ENERGY METABOLISM; HEMODYNAMIC PROCESSES; HUMANS; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; OXYGEN CONSUMPTION;

EID: 0034207848     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/713783125     Document Type: Review

References (89)

1. Yeo GF. An attempt to estimate the gaseous interchange of the dog's heart by means of the spectroscope. J Physiol 1885; 6: 93-121.
2. Sarnoff SJ, Braunwald E, Welch GH, Case RB, Stainsby WN, Macruz R. Hemodynamic determinants of oxygen consumption of the heart with special reference to the tension-time index. Am J Physiol 1958; 192: 148-156.
3. Britman NA, Levine HJ. Contractile element work: a major determinant of myocardial oxygen consumption. J Clin Invest 1964; 43: 1397-1408.
4. Rooke GA, Feigl EO. Work as a correlate of canine left ventricular oxygen consumption, and the problem of catecholamine oxygen wasting. Circ Res 1982; 50: 273-286.
5. Suga H. Ventricular energetics. Physiol Rev 1990; 70: 247-277.
6. Korvald C, Elvenes OP, Myrmel T. Myocardial substrate metabolism influences left ventricular energetics in vivo. Am J Physiol Heart Circ Physiol 2000; 278: H1345-1351.
7. 2+ sensitizer, MCI-154, on the myocardial oxygen consumption-cardiac output relation in patients with left ventricular dysfunction after myocardial infarction: comparison with dobutamine and phosphodiesterase inhibitor. Am Heart J 1997; 133: 283-289.
8. Korvald C, Elvenes OP, Ytrebø LM, Sørlie DG, Myrmel T. Oxygen wasting effect of inotropy in the "Virtual work" model. Am J Physiol 1999; 276: H1339-1345.
9. Hisano R, Cooper IV G. Correlation of force-length area with oxygen consumption in ferret papillary muscle. Circ Res 1987; 61: 318-328.
10. Mast F, Elzinga G. Heat released during relaxation equals force-length area in isometric contractions of rabbit papillary muscle. Circ Res 1990; 67: 893-901.
11. Elbeery JR, Lucke JC, Feneley P, et al. Mechanical determinants of myocardial oxygen consumption in conscious dogs. Am J Physiol 1995; 269: H609-620.
12. Lucke JC, Elbeery JR, Koutlas TC, et al. Effects of cardiac glycosides on myocardial function and energetics in conscious dogs. Am J Physiol 1994; 267: H2042-2049.
13. Alpert NR, Blanchard EM, Mulieri LA. Tension-independent heat in rabbit papillary muscle. J Physiol 1989; 414: 433-453.
14. Holroyd SM, Gibbs CL. Is there a shortening-heat component in mammalian cardiac muscle contraction? Am J Physiol 1992; 262: H200-208.
15. Huxley HE. Sliding filaments and molecular motile systems. J Biol Chem 1990; 265: 8347-8350.
16. Backx P. Efficiency of cardiac muscle: thermodynamic and statistical mechanical considerations. Basic Res Cardiol 1993; 88: 21-27.
17. Denslow S. Relationship between PVA and myocardial oxygen consumption can be derived from thermodynamics. Am J Physiol 1996; 270: H730-740.
18. Taylor TW, Goto Y, Suga H. Variable cross-bridge cycling-ATP coupling accounts for cardiac mechanoenergetics. Am J Physiol 1993; 264: H994-1004.
19. Yamaguchi H, Takaki M, Matsubara H, Yasuhara S, Suga H. Constancy and variability of contractile efficiency as a function of calcium and cross-bridge kinetics: simulation. Am J Physiol 1996; 270: H1501-1508.
20. Yasumura Y, Nozawa T, Futaki S, Tanaka N, Suga H. Time-invariant oxygen cost of mechanical energy in dog left ventricle: consistency and inconsistency of time-varying elastance model with myocardial energetics. Circ Res 1989; 64: 764-778.
21. Hata K, Goto Y, Suga H. External mechanical work during relaxation period does not affect myocardial oxysen consumption. Am J Physiol 1991; 261: H1778-1784.
22. Suga H, Hisano R, Goto Y, Yamuda O, Igarashi Y. Effect of positive inotropic agents on the relation between oxygen consumption and systolic pressure volume area in canine left ventricle. Circ Res 1983; 53: 306-318.
23. Ohgoshi Y, Goto Y, Kawaguchi O, et al. Epinephrine and calcium have similar oxygen costs of contractility. Heart Vessels 1992; 7: 123-132.
24. Hata K, Goto Y, Futaki S, et al. Mechanoenergetic effects of pimobendan in canine left ventricles. Comparison with dobutamine. Circulation 1992; 86: 1291-1301.
25. Ohgoshi Y, Goto Y, Futaki S, Yaku H, Kawaguchi O, Suga H. Increased oxygen cost of contractility in stunned myocardium in dog. Circ Res 1991; 69: 975-988.
26. Yaku H, Goto Y, Ohgoshi Y, et al. Determinants of myocardial oxygen consumption in fibrillating dog hearts. J Thorac Cardiovasc Surg 1993; 105: 679-687.
27. Alpert NR, Mulieri LA, Heat, mechanics and myosin ATPase in normal and hypertrophied heart muscle. FASEB J 1982; 41: 192-198.
28. Chapman JB. Heat production. In: Drake-Holland AJ, Noble MIM, eds. Cardiac Metabolism. Chichester, UK: Wiley, 1983: 239-256.
29. Gibbs CL, Chapman JB. Cardiac mechanics and energetics: chemomechanical transduction in cardiac muscle. Am J Physiol 1985; 249: H199-206.
30. Homsher E. Muscle enthalpy production and its relation to actinomyosin ATPase. Ann Rev Physiol 1987; 49: 673-690.
31. 2 use of unloaded contracting rat heart slices: Thapsigargin and cyclopiazonic acid. J Mol Cell Cardiol 1998; 30: 649-659.
32. Myrmel T, Forsdahl K, Larsen TS. Triacylglycerol metabolism in hypoxic, glucose-deprived rat cardiomyocytes. J Mol Cell Cardiol 1992; 8: 855-868.
33. Mjøs OD. Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs. J Clin Invest 1971; 50: 1386-1389.
34. Yanagida T, Huradu Y, Ishijima A. Nano-manipulation of actomyosin molecular motors in vitro: a new working principle. TIBS 1993; 18: 319-324.
35. Yanagida T, Arata T, Oosawa F. Sliding distance of actin filament induced by a myosin crossbridge during one ATP hydrolysis cycle. Nature 1985; 316: 366-369.
36. Lombardi V, Piazzesi G, Linari M. Rapid regeneration of the actin-myosin power stroke in contracting muscle. Nature 1992; 355: 638-641.
37. Klocke FJ, Kaiser GA, Ross J, Braunwald E. Mechanism of increase of myocardial oxygen uptake produced by catecholamines. Am J Physiol 1965; 209: 913-918.
38. 2 consumption in normal heart: effects of dobutamine. Am J Physiol 1993; 265: H1884-1892.
39. Packer M, Bristow MR, Conn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349-1355.
40. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HP). Lancet 1999; 353: 2001-2007.
41. Ingwall JS. Is cardiac failure a consequence of decreased energy reserve. Circulation 1993; 87 Suppl VII: VII58-VII62.
42. Benotti JR, Grossman W, Braunwald E, Carabello BA. Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease. Circulation 1980; 62: 28-34.
43. Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 1991; 325: 1468-1475.
44. Goto Y, Slinker BK, LeWinter MM. Effects of amrinone and isoproterenol on mechanoenergetics of blood-perfused rabbit heart. Am J Physiol 1992; 262: H719-727.
45. Hasenfuss G, Holubarsch Ch, Just H, Blanchard E, Mulieri LA, Alpert NR. Energetic aspects of inotropic interventions in rat myocardium. Basic Res Cardiol 1987; 82 Suppl 2: 251-259.
46. Nielsen-Kudsk JE, Aldershvile J. Will calcium sensitizers play a role in the treatment of heart failure? J Cardiovasc Pharmacol 1995; 26: S77-84.
47. ++ sensitivity of contractile proteins. Circulation 1986; 73 Suppl III: III78-84.
48. de Tombe PP, Burkhoff D, Hunter WC. Effects of calcium and EMD-53998 on oxygen consumption in isolated canine hearts. Circulation 1992; 86: 1945-1954.
49. 2+ in isolated ferret cardiac muscle. Circ Res 1993; 73: 61-70.
50. 2+ sensitizer, decreases the oxygen cost of contractility in isolated canine hearts. Am J Physiol 1997; 273: H1688-1695.
51. Mori M, Takeuchi M, Takaoka H, et al. Oxygen-saving effect of a new cardiotonic agent, MCI-154, in diseased human hearts. J Am Coll Cardiol 1997; 29: 613-622.
52. Lilleberg J, Nieminen MS, Akkila J, et al. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J 1998; 19: 660-668.
53. Perez NG, Gao WD, Marban E. Novel myofilament calcium-sensitizing property of xanthine oxidase inhibitors. Circ Res 1998; 83: 423-430.
54. Ekelund UE, Harrison RW, Shokek O, et al. Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure. Circ Res 1999; 85: 437-445.
55. Feldman MD, Pak PH, Wu CC, et al. Acute cardiovascular effects of OPC-18790 in patients with congestive heart failure. Time- and dose-dependence analysis based on pressure-volume relations. Circulation 1996; 93: 474-483.
56. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429-1435.
57. Shen W, Xu X, Ochoa M, Zhao G, Wolin MS, Hintze TH. Role of nitric oxide in the regulation of oxygen consumption in conscious dogs. Circ Res 1994; 75: 1086-1095.
58. Zhang X, Xie Y-W, Nasjletti A, Xu X, Wolin MS, Hintze TH. ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption. Circulation 1997; 95: 176-182.
59. Laursen JB, Harrison DG. Modulation of myocardial oxygen consumption through ACE inhibitors. No effect? Circulation 1997; 95: 14-16.
60. Loke KE, McConnell PI, Tuzman JM, et al. Endogenous endothelial nitric oxide synthetase/derived nitric oxide is a physiological regulator of myocardial oxygen consumption. Circ Res 1999; 84: 840-845.
61. Ingwall JS, Kelly RA. Nitric oxide, myocardial oxygen consumption, and ATP synthesis. Circ Res 1998; 83: 1067-1068.
62. Wittstein IA, Kass DA, Maughan WL, Pak PH, Fetics B, Hare JM. Angiotensin converting enzyme inhibitors have a nitric oxide modulated negative inotropic effect in patients with left ventricular dysfunction. J Am Coll Cardiol 1998; 31: 81A.
63. Suto N, Mikuniya A, Okubo T, Hanada H, Shinozaki N, Okumora K. Nitric oxide modulates cardiac contractility and oxygen consumption without changing contractile efficiency. Am J Physiol 1998; 275: H41-49.
64. Krukenkamp IB, Silverman NA, Sorlie D, et al. Characterization of postischemic myocardial oxygen utilization. Circulation 1986; 74 Suppl III: III-125-129.
65. Laxson DD, Homans DC, Dai X-Z, Sublett E, Bache RJ. Oxygen consumption and coronary reactivity in post-ischemic myocardium. Circ Res 1989; 64: 9-20.
66. Stahl LD, Weiss HR, Becker LC. Myocardial oxygen consumption, oxygen supply/demand heterogeneity, and microvascular patency in regionally stunned myocardium. Circulation 1988; 77: 865-872.
67. Krukenkamp I, Silverman N, Sorlie D, Pridjian A, Feinberg H, Levitsky S. Myocardial energetics after thermally graded hyperkalemic crystalloid cardioplegic arrest. J Thorac Cardiovasc Surg 1986; 92: 56-62.
68. Laster SB, Decker LC, Ambrosio G, Jacobus WE. Reduced aerobic metabolic efficiency in globally "stunned" myocardium. J Mol Cell Cardiol 1989; 21: 419-426.
69. Schipke JD, Sunderdiek U, Korbmacher B, Schwanke U, Arnold G. Utilization of oxygen by the contractile apparatus is disturbed during reperfusion of post-ischaemic myocardium. Eur Heart J 1995; 16: 1476-1481.
70. McFalls EO, Duncker DJ, Krams R, Sassen LMA, Hoogendoorn A, Verdouw PD. Recruitment of myocardial work and metabolism in regionally stunned porcine myocardium. Am J Physiol 1992; 263: H1724-1731.
71. Krams R, Janssen M, Van der Lee C, et al. Loss of elastic recoil in postischemic myocardium induces rightward shift of the systolic pressure-volume relationship. Am J Physiol 1994; 267: H1557-1564.
72. Dean EN, Shlafer M, Nicklas JM. The oxygen consumption paradox of "stunned myocardium" in dogs. Basic Res Cardiol 1990; 85: 1230-1231.
73. Vanoverschelde J-L J, Wijns W, Depré C, et al. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation 1993; 87: 1513-1523.
74. 31P NMR. J Biol Chem 1988; 263: 10600-10607.
75. Zimmer SD, Ugurbil K, Michurski SP, et al. Alterations in oxidative function and respiratory regulation in the post-ischemic myocardium. J Biol Chem 1989; 264: 12402-12411.
76. Benzi RH, Lerch R. Dissociation between contractile function and oxidative metabolism in postischemic myocardium. Attenuation by ruthenium red administered during reperfusion. Circ Res 1992; 71: 567-576.
77. Liedtke AJ, DeMaisin L, Eggleston AM, Cohen LM, Nellis SH. Changes in substrate metabolism and effects of excess fatty acids in reperfused myocardium. Circ Res 1988; 62: 535-542.
78. Tamm C, Benzi R, Papageorgiou I, Tardy I, Lerch R. Substrate competition in postischemic myocardium. Circ Res 1994; 75: 1103-1112.
79. Furukawa S, Kreiner G, Bavaria JE, Streicher JT, Edmunds LH. Recovery of oxygen utilization efficiency after global myocardial ischemia. Ann Thorac Surg 1991; 52: 1063-1068.
80. Hasenfuss G, Mulieri LA, Blanchard EM, Holubarsch C, et al. Energetics of isometric force development in control and volume-overload human myocardium. Circ Res 1991; 68: 836-846.
81. Hasenfuss G, Mulieri LA, Leavitt BJ, Allen PD, Haeberle JR, Alpert NR. Alteration of contractile function and excitation-contraction coupling in dilated cardiomyopathy. Circ Res 1992; 70: 1225-1232.
82. Vogt M, Jacob R, Kissling G, Rupp H. Chronic cardiac reactions. II. Mechanical and energetic consequences of myocardial transformation versus ventricular dilatation in the chronically pressure-loaded heart. Basic Res Cardiol 1987; 82 Suppl 2: 147-159.
83. Wolff MR, de Tombe PP, Harasawa Y, et al. Alterations in left ventricular mechanics, energetics, and contractile reserve in experimental heart failure. Circ Res 1992; 70: 516-529.
84. Hayashi Y, Takeuchi M, Takaoka H, Hata K, Mori M, Yokoyama M. Alteration in energetics in patients with left ventricular dysfunction after myocardial infarction. Increased oxygen cost of contractility. Circulation 1996; 93: 932-939.
85. Depre C, Shipley GL, Davies PJ, Frazier OH, Taegtmeyer H. Glucose transporter isoform expression in the failing human heart. Circulation 1998; 98: 1627.
86. Strauer BE. Cardiac energetics in clinical heart disease. Basic Res Cardiol 1987; 82 Suppl 2: 389-402.
87. Green GR, Moon MR, DeAnda A, Daughters GT Jr. Glasson JR, Miller DC. Effects of partial left ventriculectomy on left ventricular geometry and wall stress in excised porcine hearts. J Heart Valve Dis 1998; 5: 474-483.
88. Krukenkamp IB, Levitsky S. Myocardial oxygen consumption after fibrillation in the nonhypertrophied porcine ventricle. Ann Thorac Surg 1991; 52: 949-954.
89. Hottenrott CE, Towers B, Kurkji HJ, Maloney JV, Buckberg GD. The hazards of ventricular fibrillation in hypertrophied ventricles during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1973; 66: 742-753.